Sutro Biopharma, Inc.
STRO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$56,857 | -$11,499 | -$75,968 | -$72,443 |
| Dep. & Amort. | $1,900 | $1,900 | $1,900 | $1,868 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $5,263 | $5,538 | $5,915 |
| Change in WC | $4,649 | -$50,581 | -$9,146 | -$15,735 |
| Other Non-Cash | $12,119 | $10,193 | $9,793 | $8,657 |
| Operating Cash Flow | -$38,189 | -$44,724 | -$67,883 | -$71,738 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$251 | -$86 | -$1,174 | -$1,068 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$89,938 | -$28,593 | -$142,380 | -$126,031 |
| Inv. Sales/Matur. | $130,178 | $31,259 | $127,296 | $214,587 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $39,989 | $2,580 | -$16,258 | $87,488 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $127 | $0 | $246 | $0 |
| Stock Repurch. | $0 | -$60 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$25 | $0 | -$180 | -$24 |
| Financing Cash Flow | $102 | -$60 | $66 | -$24 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,902 | -$42,204 | -$84,075 | $15,726 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $64,025 | $107,087 | $191,162 | $175,436 |
| End Cash | $65,927 | $64,883 | $107,087 | $191,162 |
| Free Cash Flow | -$38,440 | -$44,810 | -$69,057 | -$72,806 |